Hiroaki Hondoh

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.

Journal: International journal of clinical oncology
Published: August 31, 2022

Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.

Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.

Journal: PloS one
Published: January 25, 2021

GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.

GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.

Journal: Scientific reports
Published: July 12, 2019

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.

Journal: BMC cancer
Published: January 23, 2019

Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.

Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.

Journal: Scientific reports
Published: December 18, 2018

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.

Journal: PloS one
Published: November 26, 2018

MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.

MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.

Journal: PloS one
Published: September 03, 2018

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.

Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.

Journal: Oncotarget
Published: February 21, 2018

Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.

Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.

Journal: Anticancer research
Published: August 29, 2017

Long-term survivors of primary central nervous system lymphoma.

Long-term survivors of primary central nervous system lymphoma.

Journal: Japanese journal of clinical oncology
Published: July 13, 2016

Late relapse of primary central nervous system lymphoma.

Late relapse of primary central nervous system lymphoma.

Journal: Leukemia & lymphoma
Published: July 12, 2016

Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.

Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 22, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026